Precipio Inc (PRPO) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Precipio Inc stock $6.35, price $18.62, that is 65.9% below the price, quality 49 out of 100. Rating: strongly overvalued. Calculated from audited financials with 11 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.
How to read this chart
60‑month range $4.44 – $72.60 · fair‑value band $4.79 – $8.64 · the $18.62 price screens above the $6.35 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.
Follow Precipio in your weekly email
Every Wednesday you see whether Precipio is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services.
Show moreShow less
The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers.
Precipio, Inc. is based in New Haven, Connecticut.
Stock analysis
Precipio Inc (PRPO) currently trades at $18.62, while our model-based Fair Value estimate is $6.35, 66% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of $7.82 per share, and 0 of the 11 models we run sit above the $18.62 price.
Bear case: the Asset-Based group reads lowest at $1.36, and 11 of the 11 models stay below the price. Data coverage for this calculation is low.
Scenario range: $4.79 (bear) to $8.64 (bull), the price of $18.62 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 49/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Precipio Inc reported revenue of $24.0M in FY2025 versus $8.8M in FY2021, a compound +28.4%/yr. Reported net income was −$363K in FY2025.
Key figures
Market cap $33.3M Micro · P/S ratio 1.24 · EPS (TTM) $−0.6400 · Net margin −4.5% · Return on equity −9.0% · Return on assets (EBIT) −32.7% (5-year average) · Operating margin −8.5% · Revenue (TTM) $27.2M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 11 out of 100 (low confidence).
What moves the price
The share trades about 42% below its 52-week high and 5% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −9% fair-value upside, at −66%, PRPO screens richer than that median.
Fair Value models
Bear$4.79Fair Value $6.35Bull$8.64
Price $18.62 · Downside -65.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF$6.20$8.31$13.2280
Growth DCF$6.11$8.45$11.7979
Owner Earnings$5.62$7.67$11.2477
All 11 models by family
DCF Models
FCF DCF$6.20$8.31$13.2280
Owner Earnings$5.62$7.67$11.2477
5Y Revenue Exit$5.52$7.23$9.6374
5Y EBITDA Exit$5.63$7.47$9.8676
10Y Revenue Exit$5.67$7.38$10.1667
10Y EBITDA Exit$5.80$7.54$10.3569
Multiples
EV/EBITDA$3.46$4.16$4.8767
EV/Revenue$3.16$3.94$4.7254
Asset-Based
NCAV (Graham)$1.02$1.36$2.0354
Growth DCF
Growth DCF$6.11$8.45$11.7979
Rev-Margin DCF$5.52$7.18$9.4974
The fair value above starts from this blend and is adjusted for dilution from new shares.
In the last 6 months, one officer or director sold shares worth $100,296 and none bought.
SaleRichard A SandbergDirector2× since May 19, 2026: 4,034 shares, avg. $24.86$100,296May 21, 2026
BuyAhmed Zaki SabetChief Operating Officer2× since Jan 2, 2026: 39 shares, avg. $25.61$999Apr 1, 202610b5-1 plan
Plus 5 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+50.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+36.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+31.6%
Start year 2020 (pandemic). Over 10 years: +30.7% a year
Revenue growth 26 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.2%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−150.1% (2020) → −5.0% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+37.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +34.6% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 126 stocks
Beats the industry median on 3/10 measures
Overall it trails its industry peers.
Valuation
Quality Score49 · Below median
Fair Value upside−65.9% · Bottom 25%
Profitability
Return on assets−1.7% · Below median
Net margin (12 months)−4.5% · Below median
Operating margin (12 months)−8.5% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)24.2% · Top 25%
Balance sheet
Debt / equity0.00× · Below median
Valuation Multiplesvs Diagnostics & Research median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Precipio Inc Fair Value". https://www.fairvalue-calculator.com/stock/PRPO
Frequently asked questions
Is Precipio Inc (PRPO) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of $6.35 versus a price of $18.62, about 66% lower (overvalued).
What is the fair value of PRPO?
Our model-based fair value for Precipio Inc is $6.35 (as of Nov 6, 2026), built from audited fundamentals. The current price: $18.62.
What is the quality score of PRPO?
Precipio Inc has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Precipio Inc (PRPO)?
Our model-based price target is the fair value of $6.35 (as of Nov 6, 2026) from 11 valuation models. Cautious scenario $4.79, optimistic scenario $8.64. It is a calculation from audited fundamentals, not an analyst target.
What is the Precipio Inc stock forecast for 2026?
Our models put fair value at $6.35, about 66% lower versus a price of $18.62 (overvalued). Cautious scenario $4.79, optimistic scenario $8.64. The calculation is refreshed regularly with new filings.
What is the revenue of Precipio Inc (PRPO)?
Precipio Inc reported trailing-twelve-month revenue of about $27.2M (latest available figure, as of Nov 6, 2026).
What growth is priced into Precipio Inc (PRPO)?
For today's price to be fair in a discounted-cash-flow model, Precipio Inc would have to grow free cash flow by +37.8 % per year for five years (discount rate 10.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +31.6 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of PRPO use?
Our models discount Precipio Inc at 10.5 %: a base by market capitalisation (nano), damped by beta 1.30, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Precipio Inc that is +37.8 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.5 %) and the same formula as our fair value.
How much growth has Precipio Inc (PRPO) delivered so far?
Over the past 5 years revenue at Precipio Inc grew +31.6 % a year. The price currently implies free-cash-flow growth of +37.8 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Precipio Inc (PRPO) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into Precipio Inc (+37.8 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Precipio Inc (PRPO)?
The free-cash-flow yield on the price is 1.08 %: that much free cash flow Precipio Inc produces per unit of market value. When it exceeds the discount rate of our models (10.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Precipio Inc (PRPO)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Precipio Inc it is $6.35 per share (as of Nov 6, 2026), against a price of $18.62. It is the blended result of 11 valuation models in 4 families (DCF Models, Multiples, Asset-Based, Growth DCF).
Is Precipio Inc stock overvalued or undervalued in 2026?
As of Nov 6, 2026, PRPO trades above its calculated fair value: price $18.62, fair value $6.35, a gap of about −66% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PRPO?
No. The price is what the market pays today ($18.62); the fair value is what the company's own numbers justify ($6.35). For Precipio Inc the two are $12.27 per share apart. That gap is exactly why we show both numbers side by side.
How much is Precipio Inc worth?
The market values Precipio Inc at about $33.3M (market capitalisation, as of Nov 6, 2026). Per share that is $18.62; our models calculate a fair value of $6.35 per share.
What do the bullish and bearish scenarios say about PRPO?
Our models span a range for Precipio Inc: cautious scenario $4.79, base $6.35, optimistic $8.64 per share (as of Nov 6, 2026, price $18.62). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Precipio Inc (PRPO)?
Balance-sheet figures for Precipio Inc (as of Nov 6, 2026): return on equity −9.0%, debt of 0.00 per unit of equity. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is PRPO from its 52-week high?
Precipio Inc trades at $18.62, about 42% below its 52-week high of $32.37 and 5% above the low of $17.79 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $6.35 is for.
Which stocks are comparable to Precipio Inc?
From the same area (Healthcare) we also value Thermo Fisher Scientific Inc, Danaher Corporation, WuXi AppTec Co, Lonza Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Precipio Inc stock attractive at the current price?
The data as of Nov 6, 2026: price $18.62, calculated fair value $6.35 (−66%), Quality Score 49/100, from 11 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PRPO calculated?
We run Precipio Inc through 11 models from 4 families: DCF Models, Multiples, Asset-Based, Growth DCF. Every model gets the same audited fundamentals; the fair value of $6.35 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Precipio Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Precipio Inc (PRPO)?
The closing price on Nov 6, 2026 was $18.62. Our model-based fair value is $6.35, about 66% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Precipio Inc right now?
The price sits above even our optimistic bull case ($8.64). The favourable scenario is already priced in. Weak quality (49/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($4.79 to $8.64) leaves room in how you read the outcome.
Key figures of Precipio Inc
How large is the market capitalisation of Precipio Inc (PRPO)?
The market capitalisation of Precipio Inc is $33.3M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Precipio Inc (PRPO)?
The price-to-sales ratio of Precipio Inc is 1.24 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Precipio Inc (PRPO)?
Earnings per share at Precipio Inc are $−0.6400. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Precipio Inc (PRPO)?
The net margin of Precipio Inc is −4.5% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Precipio Inc (PRPO)?
The return on equity (ROE) of Precipio Inc is −9.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Precipio Inc (PRPO)?
On an EBIT basis the return on assets of Precipio Inc is −32.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Precipio Inc (PRPO)?
The operating margin of Precipio Inc is −8.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Precipio Inc (PRPO)?
Revenue at Precipio Inc is growing +24.2% versus a year earlier (3y avg +36.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net cash does Precipio Inc (PRPO) hold?
Precipio Inc holds more cash than debt, $2.4M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Precipio Inc in the live analysis
One click puts Precipio Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 6, 2026